.30 May 2019 21:30
just having a quick read at the comments today, some people are seriously downplaying the potential here after today, I don't think many are understanding the P/E ratio of pharma/ drug sectors, particularly when it comes to royalties
Assuming no dilution, stop thinking SP (yes I get 20p is 10bags etc) and look at MCAP and shares in freefloat, as an example:
10% of £400m sales on a gross royalty basis, = 40m on a conservative p/e of 20..... multiple drugs/deals in pipeline, cannabinoid, etc etc etc.. dare I say £1 is ONLY £460m mcap?
DYOR etc